| Variables |
|
DRP |
Crude OR (95% CI) |
p-value |
| |
|
Yes |
No |
|
|
| Regimen deviation |
|
118 (76.1%) |
37 (23.9%) |
1.16 (0.72-1.87) |
0.545 |
| Inappropriate BSA |
|
28 (100%) |
0 (0%) |
|
0.998 |
| * undetermined metastasis stage |
|
136 (74.3%) |
47 (25.7%) |
1 (0.64-1.64) |
0.929 |
| Use of in appropriate lab results |
|
17 (94.4%) |
1 (5.6%) |
6.133 (0.805-46.74) |
0.08 |
| Sex |
Male |
139 (77.2%) |
41 (22.8%) |
1 |
|
| |
Female |
133 (71.9%) |
52 (28.1%) |
1.326 (0.83-2.13) |
0.243 |
| Age |
70-79 |
4 (80%) |
1 (20%) |
1.4 (0.15-12.9) |
0.769 |
| |
60-69 |
31 (83.8%) |
6 (16.2%) |
1.8 (0.697-4.65) |
0.224 |
| |
50-59 |
80 (72.1%) |
31 (27.9%) |
0.9 (0.52-1.57) |
0.709 |
| |
40-49 |
48 (73.8%) |
17 (26.2%) |
0.98 (0.51-1.9) |
0.963 |
| |
< 40 |
109 (74.1%) |
38 (25.9%) |
1 |
0.722 |
| Co-morbidity |
Yes |
69 (88.5%) |
9 (11.5%) |
3.2 (1.514-6.65) |
0.002 |
| Hospital stay |
1-2 |
142 (67.9%) |
67 (32.1%) |
1 |
|
| (days) |
3-10 |
130 (83.3%) |
26 (16.7%) |
2.36 (1.414-3.94) |
0.001 |
| No. of Meds |
|
|
|
1.4 (1.0-1.85) |
0.02 |
| |
|
|
|
|
|
|
| *undetermined metastasis stage indicates metastasis stage is unknown or not
described in patient chart |
| Table 4: Univariate Logistic Regression results for individual risk factors. |
